I'm surprised this study didn't segment a portion of the subjects as diabetic and I wonder if such a sub-group would potentially have seen an improvement over non-diabetic subjects.

I'm sure this isn't the last we will hear of the potential of GLP1s in neurological diseases.

At the same time, our work in neurostimulation of slow-wave sleep is showing promise with a correlation between neurostimulation response, amyloid response, and memory in healthy older adults[1], as well as tolerance of stimulation in people living with Alzheimer's [2]. More studies to be done, but if you're curious, we link to a large body of research on our website https://www.affectablesleep.com/how-it-works?type=All#resear...

[1] https://doi.org/10.1093/ageing/afad228 [2] https://doi.org/10.1016/j.jagp.2024.07.002